{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:31:10Z","timestamp":1790040670295,"version":"4.0.1"},"reference-count":28,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.3892\/or.2017.5993","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T04:11:11Z","timestamp":1506312671000},"page":"3160-3166","source":"Crossref","is-referenced-by-count":7,"title":["Enhanced wild-type p53 expression by small activating RNA dsP53-285 induces cell cycle arrest and apoptosis in pheochromocytoma cell line PC12"],"prefix":"10.3892","volume":"38","author":[{"given":"Dengqiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpo","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"key20180107220427_b1-or-38-05-3160","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"key20180107220427_b2-or-38-05-3160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/ejso.2002.1413","article-title":"The management of benign and malignant pheochromocytoma and abdominal paraganglioma","volume":"29","author":"Edstr\u00f6m Elder","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"key20180107220427_b3-or-38-05-3160","first-page":"106","article-title":"Preoperative diagnosis of suspected pheochromocytoma - retrospective assessment of diagnostic criteria","volume":"15","author":"Sch\u00fcrmeyer","year":"1988","journal-title":"Acta Med Austriaca"},{"key":"key20180107220427_b4-or-38-05-3160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MED.0000000000000330","article-title":"Malignant pheochromocytoma-paraganglioma: Pathogenesis, TNM staging, and current clinical trials","volume":"24","author":"Roman-Gonzalez","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key20180107220427_b5-or-38-05-3160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004320000170","article-title":"Clinical management of malignant adrenal tumors","volume":"127","author":"Kopf","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107220427_b6-or-38-05-3160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: New functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"key20180107220427_b7-or-38-05-3160","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: The cell's response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107220427_b8-or-38-05-3160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.cdd.4401183","article-title":"Decision making by p53: Life, death and cancer","volume":"10","author":"Oren","year":"2003","journal-title":"Cell Death Differ"},{"key":"key20180107220427_b9-or-38-05-3160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107220427_b10-or-38-05-3160","first-page":"483","article-title":"Mutations of the p53 gene in human functional adrenal neoplasms","volume":"78","author":"Lin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107220427_b11-or-38-05-3160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1590247","article-title":"The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas","volume":"159","author":"Yoshimoto","year":"1998","journal-title":"J Endocrinol"},{"key":"key20180107220427_b12-or-38-05-3160","doi-asserted-by":"crossref","first-page":"e8848","DOI":"10.1371\/journal.pone.0008848","article-title":"RNAa is conserved in mammalian cells","volume":"5","author":"Huang","year":"2010","journal-title":"PLoS One"},{"key":"key20180107220427_b13-or-38-05-3160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"key20180107220427_b14-or-38-05-3160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/MCB.11.1.12","article-title":"Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes","volume":"11","author":"Milner","year":"1991","journal-title":"Mol Cell Biol"},{"key":"key20180107220427_b15-or-38-05-3160","unstructured":"KatoSHanSYLiuWOtsukaKShibataHKanamaruRIshiokaCUnderstanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysisProc Natl Acad Sci USA10084248429200310.1073\/pnas.143169210012826609166245"},{"key":"key20180107220427_b16-or-38-05-3160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/modpathol.2008.104","article-title":"Clinical significance of p53 alterations in surgically treated prostate cancers","volume":"21","author":"Schlomm","year":"2008","journal-title":"Mod Pathol"},{"key":"key20180107220427_b17-or-38-05-3160","first-page":"231","article-title":"Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells","volume":"9","author":"Ge","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20180107220427_b18-or-38-05-3160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-016-0329-8","article-title":"Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis","volume":"35","author":"Wang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107220427_b19-or-38-05-3160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/377552a0","article-title":"Radiation-induced cell cycle arrest compromised by p21 deficiency","volume":"377","author":"Brugarolas","year":"1995","journal-title":"Nature"},{"key":"key20180107220427_b20-or-38-05-3160","first-page":"5187","article-title":"p21 is necessary for the p53-mediated G1 arrest in human cancer cells","volume":"55","author":"Waldman","year":"1995","journal-title":"Cancer Res"},{"key":"key20180107220427_b21-or-38-05-3160","first-page":"177","article-title":"Cyclin D1 and p21\/waf1 are both involved in p53 growth suppression","volume":"12","author":"Del Sal","year":"1996","journal-title":"Oncogene"},{"key":"key20180107220427_b22-or-38-05-3160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"key20180107220427_b23-or-38-05-3160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA","volume":"369","author":"Waga","year":"1994","journal-title":"Nature"},{"key":"key20180107220427_b24-or-38-05-3160","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jcb.21707","article-title":"Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities","volume":"104","author":"Plati","year":"2008","journal-title":"J Cell Biochem"},{"key":"key20180107220427_b25-or-38-05-3160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107220427_b26-or-38-05-3160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2559.2004.01750.x","article-title":"Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers","volume":"44","author":"Groeger","year":"2004","journal-title":"Histopathology"},{"key":"key20180107220427_b27-or-38-05-3160","unstructured":"LiLCOkinoSTZhaoHPookotDPlaceRFUrakamiSEnokidaHDahiyaRSmall dsRNAs induce transcriptional activation in human cellsProc Natl Acad Sci USA1031733717342200610.1073\/pnas.0607015103170855921859931"},{"key":"key20180107220427_b28-or-38-05-3160","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/138920110791591463","article-title":"Defining features and exploring chemical modifications to manipulate RNAa activity","volume":"11","author":"Place","year":"2010","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:05:12Z","timestamp":1515344712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,25]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.3892\/or.2017.5993"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5993","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]}}}